Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors
Clinical trial NCT05740215 · UNKNOWN
Trial details
- NCT number
- NCT05740215
- Sponsor
- Shandong New Time Pharmaceutical Co., LTD
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-23
- Primary completion
- 2024-05-22
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.